Your browser doesn't support javascript.
loading
Putaminal dopamine modulates movement motivation in Parkinson's disease.
Banwinkler, Magdalena; Dzialas, Verena; Rigoux, Lionel; Asendorf, Adrian L; Theis, Hendrik; Giehl, Kathrin; Tittgemeyer, Marc; Hoenig, Merle C; van Eimeren, Thilo.
Afiliación
  • Banwinkler M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, 50937 Cologne, Germany.
  • Dzialas V; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, 50937 Cologne, Germany.
  • Rigoux L; University of Cologne, Faculty of Mathematics and Natural Sciences, 50939 Cologne, Germany.
  • Asendorf AL; Max Planck Institute for Metabolism Research, 50931 Cologne, Germany.
  • Theis H; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, 50937 Cologne, Germany.
  • Giehl K; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, 50937 Cologne, Germany.
  • Tittgemeyer M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, 50937 Cologne, Germany.
  • Hoenig MC; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, 50937 Cologne, Germany.
  • van Eimeren T; Research Center Juelich, Institute for Neuroscience and Medicine II, Molecular Organization of the Brain, 52425 Juelich, Germany.
Brain ; 2024 Jun 28.
Article en En | MEDLINE | ID: mdl-38941444
ABSTRACT
The relative inability to produce effortful movements is the most specific motor sign of Parkinson's disease, which is primarily characterized by loss of dopaminergic terminals in the putamen. The motor motivation hypothesis suggests that this motor deficit may not reflect a deficiency in motor control per se, but a deficiency in cost-benefit considerations for motor effort. For the first time, we investigated the quantitative effect of dopamine depletion on the motivation of motor effort in Parkinson's disease. A total of 21 early-stage, unmedicated patients with Parkinson's disease and 26 healthy controls were included. An incentivized force task was used to capture the amount of effort participants were willing to invest for different monetary incentive levels and dopamine transporter depletion in the bilateral putamen was assessed. Our results demonstrate that patients with Parkinson's disease applied significantly less grip force than healthy controls, especially for low incentive levels. Congruously, decrease of motor effort with greater loss of putaminal dopaminergic terminals was most pronounced for low incentive levels. This signifies that putaminal dopamine is most critical to motor effort when the trade-off with the benefit is poor. Taken together, we provide direct evidence that the reduction of effortful movements in Parkinson's disease depends on motivation and that this effect is associated with putaminal dopaminergic degeneration.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Brain Año: 2024 Tipo del documento: Article